1. You are here:
  2. Homepage
  3. News & Insights Search
  4. Canada: Health Canada Issues Final Guidance On Pre-market Evaluation of Hepatotoxicity

rf-fullcolor.png

 

Regulatory News
April 19, 2012
by Ansis Helmanis

Canada: Health Canada Issues Final Guidance On Pre-market Evaluation of Hepatotoxicity

Health Canada issued final guidance to sponsors yesterday on the detection, assessment, mitigation and reporting of hepatoxicity for pharmaceuticals, radiopharmaceuticals and biologic drugs for human use. 

A draft version of the guidance was first released for consultation on 16 February 2011. 

There were 125 comments received and changes were incorporated where appropriate. 


Read more:

Health Canada - Guidance Document: Pre-market Evaluation of Hepatotoxicity in Health Products

More Breaking News from RegLink

Return to listing
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.